Shan Dong Kexing Bioproducts Co (SHSE:688136) LT-Debt-to-Total-Asset : 0.21 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Shan Dong Kexing Bioproducts Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shan Dong Kexing Bioproducts Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.21.

Shan Dong Kexing Bioproducts Co's long-term debt to total assets ratio declined from Mar. 2023 (0.28) to Mar. 2024 (0.21). It may suggest that Shan Dong Kexing Bioproducts Co is progressively becoming less dependent on debt to grow their business.

Shan Dong Kexing Bioproducts Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Shan Dong Kexing Bioproducts Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shan Dong Kexing Bioproducts Co LT-Debt-to-Total-Asset Chart

Shan Dong Kexing Bioproducts Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.05

0.11

0.25

0.24

Shan Dong Kexing Bioproducts Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.28	0.28	0.22	0.24	0.21

Shan Dong Kexing Bioproducts Co LT-Debt-to-Total-Asset Calculation

Shan Dong Kexing Bioproducts Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	713.625	/	3031.093
	=	0.24

Shan Dong Kexing Bioproducts Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	655.045	/	3063.871
	=	0.21

Shan Dong Kexing Bioproducts Co (SHSE:688136) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Shan Dong Kexing Bioproducts Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Shan Dong Kexing Bioproducts Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Shan Dong Kexing Bioproducts Co (SHSE:688136) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shan Dong Kexing Bioproducts Co Ltd (SHSE:688136) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200

Website

http://www.kexing.com

Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.

Executives

Wang Xiao Qin	Directors, senior managers
Cui Ning	Directors, senior managers
Ma Hong Jie	senior management
Shao Ke	senior management
Deng Xue Qin	Director
Zhao Yan Qing	Directors, senior managers

Shan Dong Kexing Bioproducts Co (SHSE:688136) Headlines

No Headlines